Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Primary Antiphospholipid Syndrome (PAPIRUS)
NCT03540810Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Aug 2018
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in antiphospholipid syndrome (APS), sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT03540810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540810.